Drug Delivery Devices Market Growth Opportunities, Key Trends And Forecast 2025-2034

Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts

How does the forecasted CAGR of the drug delivery devices industry compare to other sectors?

The drug delivery devices market size has grown strongly in recent years. It will grow from $91.03 billion in 2024 to $96.73 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rapid growth in elderly population, growth in the number of healthcare facilities, economic growth in the emerging markets and increased healthcare expenditure.

The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $124.82 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increase in prevalence of chronic diseases, increasing demand from injectables, increasing demand for drug delivery devices and sudden emergence of severe infections. Major trends in the forecast period include investing in microneedle drug technology for drug delivery, research and development of self-injectable drug delivery devices, focusing on mergers and acquisitions and investing in wearable drug delivery devices.

Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What market trends are acting as primary growth drivers for the drug delivery devices sector?
The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and other diseases is expected to drive the drug delivery devices market. For instance, in January 2023, according to the National Library of Medicine, a US-based medical library operated by the federal government, the number of individuals in the United States aged 50 and older who have at least one chronic condition is projected to increase by 99.5%. This increase would see the number rise from 71.522 million in 2020 to 142.66 million by 2050. There are various routes of drug administration for medical drugs. The development of new drug delivery systems plays a major role in the pharmaceutical industry. Research and development (R&D) in drug delivery is increasing throughout the world due to the increasing prevalence of these diseases. Most pharmaceutical companies are focusing on multiple drug delivery technologies to create excellent advantages and better outcomes for their marketed products. Hence, the increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market.

What are the fastest-growing segments in the drug delivery devices market forecast period?
The drug delivery devices market covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Which trends are expected to dominate the drug delivery devices market landscape in the coming years?
Major companies operating in the drug delivery device market are focusing on developing innovative devices such as autoinjectors with completely built-in connectivity to gain a competitive edge in the market. Autoinjectors are medical devices designed for the self-administration of a pre-measured dose of medication. For instance, in May 2022, Jabil Healthcare, a US-based provider of healthcare manufacturing solutions, launched the Qfinity autoinjector platform, a reusable drug delivery device. The Qfinity autoinjector platform stands out as a simple, reusable, and modular solution for subcutaneous drug self-administration, offering a cost-effective alternative to market competitors while promoting sustainable drug delivery in the pharmaceutical industry. With its versatile design, it accommodates various drug volumes and viscosities, featuring a patient-centric form factor that provides up to 65% lower cost per injection compared to leading disposable autoinjectors. The durable Qfinity device supports over 100 injections and utilizes 1 mL or 2.25 mL pre-filled disposable cassettes. Additionally, its reduced component and material consumption results in an estimated 65% decrease in cost per injection, a 60% smaller carbon footprint, a 50% reduction in manufacturing footprint, and a 70% decrease in capital expenditure (CAPEX).

Which major players hold significant market share in the drug delivery devices sector?
Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

Which regional segments are forecasted to witness the fastest growth in the drug delivery devices market?
North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Can Companies Use The Drug Delivery Devices Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

Need Customized Data On Drug Delivery Devices Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company